Thermo Fisher Launches Molecular Diagnostic System for Lung Transplant Rejection Assessment
The machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
Category: Molecular Diagnostic Analyzers
Molecular Diagnostic Analyzers
Latest
Molecular Diagnostic Analyzers
Latest
Alveo Technologies Completes Expanded CDC Agreement for Seasonal and Avian Influenza Test
The company's be.well platform can detect seasonal influenza A and B as well as avian influenza A(H5) in humans within 45 minutes at the point of care.
Molecular Diagnostic Analyzers
Latest
Sepsis Test Shows the Value of Rapid Diagnosis  Â
Two case studies illustrate how a newly developed sepsis test improves turnaround times and diagnostic accuracy.
QIAGEN Upgrades its Syndromic Testing Analyzer
The QIAstat-Dx Analyzer 2.0 enables mobile access to test results, streamlining diagnostic processes and enhancing patient care.
Read More
BIOTYPE Upgrades Benchtop Diagnostic Platform for Multi-Gene Testing
BIOTYPE presented a major upgrade to its benchtop diagnostic platform for the fully integrated analysis of molecular biomarker signatures.
Read More
Roche Expands HPV Testing for Cobas 5800 Molecular System
Roche announced the U.S. FDA approved the cobas HPV test for use on its next-generation cobas 5800 molecular instrument.
Read More
AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage
CareDx, Inc. has announced that its AlloSure Lung donor-derived cell-free DNA molecular testing service has received Medicare coverage.
Read More
Molecular Imaging & Histology Combine for Better Cancer Diagnosis
Orion combines histologic with molecular imaging information and offers deeper insight into a tumor’s type.Â
Read More
New Centre for Phage Research features Actiphage
The first Centre for Phage Research launched on May 16 and featured in the Innovate UK KTN’s UK Phage Innovation Showcase will be Actiphage.
Read More
De Novo Submission Made for Full Clearance of its Cue RSV Molecular Test
Cue Health announced that it has made a De Novo submission to the FDA for full clearance of the Cue RSV Molecular Test.
Read More
PathogenDx Expands Reach of Multiplexed Molecular Testing Tech
PathogenDx expanded the reach of its patented multiplexed molecular testing technology, Dynamic Dimensional Detection (D3 Array).
Read More
Planned Parenthood Expands Access to STI Testing
Planned Parenthood Mar Monte (PPMM) has teamed with BD to provide STI testing for the most common infections to underserved populations.
Read More
The Opportunity to Upgrade Pharyngitis Testing
Pharyngitis testing and diagnosis can be improved by utilizing existing molecular testing capacity increased due to COVID.
Read More
As CML Outcomes Improve, Demand Rises for BCR::ABL1 Testing
Patients with chronic myeloid leukemia need regular BCR::ABL1 testing for the rest of their lives, which can translate into more lab work.
Read More
New Method for the Detection of RNA Viruses
Experts have developed a new methodology to detect RNA viruses based on the triplex-forming probe technology.
Read More
Using Electrochemical Cell-Free Biosensors for Antibody Detection
A new method of rapid, yet quantitative and specific point-of-care detection of antibodies uses an electrochemical cell-free biosensor.
Read More
COVID-19 Pandemic Pivot Shows the Benefits of Microarray Technology
PathogenDx’s involvement with Operation Warp Speed, demonstrated the efficacy of microarray technology for diagnostic testing.
Read More
DNA Testing Could Unlock Cancer’s Ancestral Roots
Researchers are revealing connections between cancer and race or ethnicity with software that infers ancestral roots in tumor DNA and RNA.
Read More